These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27418969)

  • 61. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F; Candinas R; Frielingsdorf J
    Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
    Dale KM; White CM
    Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amiodarone versus sotalol for atrial fibrillation.
    Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD;
    N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Managing atrial fibrillation in the elderly: critical appraisal of dronedarone.
    Trigo P; Fischer GW
    Clin Interv Aging; 2012; 7():1-13. PubMed ID: 22291468
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
    Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Perspectives and recommendations for the anti-arrhythmic treatment of atrial fibrillation: focus on dronedarone].
    Mélon P
    Rev Med Liege; 2011 Mar; 66(3):159-63. PubMed ID: 21560433
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dronedarone: an overview.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial.
    Salam AM
    Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1345-9. PubMed ID: 23244355
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ; Schmitt J; Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dronedarone for the Treatment of Atrial Arrhythmias in Adults With Congenital Heart Disease.
    Agha MS; Ermis PR; Franklin WJ; Parekh DR; Opina AD; Kim JJ; Miyake CY; Valdes SO; Lam WW
    Tex Heart Inst J; 2024 Apr; 51(1):. PubMed ID: 38686681
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics.
    Tave A; Goehring E; Desai V; Wu C; Bohn RL; Tamayo SG; Sicignano N; Juhaeri J; Jones JK; Weiss SR
    Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1353-1359. PubMed ID: 33730412
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
    Saklani P; Skanes A
    Curr Cardiol Rev; 2012 Nov; 8(4):302-9. PubMed ID: 22920483
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Drug safety evaluation of dronedarone in atrial fibrillation.
    De Ferrari GM; Dusi V
    Expert Opin Drug Saf; 2012 Nov; 11(6):1023-45. PubMed ID: 22971242
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Atrial fibrillation. PALLAS study: when dronedarone becomes a risk].
    Overbeck P
    MMW Fortschr Med; 2011 Dec; 153(48):18. PubMed ID: 22299248
    [No Abstract]   [Full Text] [Related]  

  • 75. Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.
    Ibrahim OA; Belley-Côté EP; Um KJ; Baranchuk A; Benz AP; Dalmia S; Wang CN; Alhazzani W; Conen D; Devereaux PJ; Whitlock RP; Healey JS; McIntyre WF
    Europace; 2021 Aug; 23(8):1200-1210. PubMed ID: 33723602
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dronedarone (Multaq) for atrial fibrillation.
    Med Lett Drugs Ther; 2009 Oct; 51(1322):78-80. PubMed ID: 19798011
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
    Le Heuzey JY; De Ferrari GM; Radzik D; Santini M; Zhu J; Davy JM
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):597-605. PubMed ID: 20384650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.
    Bonora A; Turcato G; Franchi E; Taioli G; Dilda A; Zerman G; Maccagnani A; Pistorelli C; Olivieri O
    Intern Emerg Med; 2017 Sep; 12(6):853-859. PubMed ID: 27384766
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dronedarone for atrial fibrillation therapy.
    Marzocchi M; Lombardi F
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.